Small team, agile IBUR BioSystems operates with a lean team (0-1 employees), suggesting a high dependency on strategic partnerships, channel sales, and third-party integration to scale. Target potential collaborators such as contract manufacturers, distributors, and value-added resellers to extend market reach without significant headcount.

Medical device focus The company develops diagnostic and surgical planning systems for dental implants, indicating opportunities in selling to dental clinics, oral surgeons, and hospital procurement departments. Emphasize value in workflow automation, cost efficiency, and reduced need for initial software training to appeal to budget-conscious buyers.

Low capital barrier Claim of no initial investment or software to learn presents a compelling value proposition for customers. Sales opportunities exist in pilots or subscription-based models, highlighting quick deployment, low risk, and fast time-to-value for practices exploring digital planning and guided surgery.

Patent pending edge Proprietary surgical guides with repeatable fit and hands-free operation provide a differentiator. Focus on competitive positioning around accuracy, patient comfort, and operational efficiency in clinical workflows to persuade buyers evaluating advanced planning tools.

Growth signals Revenue is under one million, indicating potential for expansion as the product matures. Target early adopters in clinics and labs, gather case studies, and leverage adjacent markets in dental implantology and surgical planning to scale through referrals and expanded product integrations.